Clinical trial
Pioglitazone as an Adjunct for Moderate to Severe Depressive Disorder
NCT01109030 is registered in ClinicalTrials.gov with Tehran University of Medical Sciences as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Pioglitazone as an Adjunct for Moderate to Severe Depressive Disorder
- Lead sponsor
- Tehran University of Medical Sciences
- Phase
- Phase 2/3
- Overall status
- Completed
- Start date
- April 30, 2010
- Completion date
- October 31, 2011
- Enrollment
- 50 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.